EUVIMEDEUVIMED entdecken
Crossref

The Fabulous Impact of CRISPR Method in Sickle Cell Disease Treatment

Vida Ebrahimi, Atieh Hashemi

Trends in Peptide and Protein Sciences · 01.04.2021

DOI: 10.22037/tpps.v6i.34202 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Trends in Peptide and Protein Sciences, erschienen am 01.04.2021. Verfasst von Vida Ebrahimi und 1 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sickle cell diseases are the most prevalent monogenic blood diseases with complications such as severe end-organ harm, pain, and reduced life expectancy. Dealing options for sickle cell diseases are inadequate, as there are just two FDA-approved drugs to decrease acute manifestation. The only sickle cell diseases curative procedure is bone marrow transplantation, frequently from a harmonized, related donor. Ex vivo manipulation of autologous hematopoietic stem and progenitor cells and subsequent transplantation of genetically altered cells theoretically offer an everlasting therapy appropriate to all sickle cell anemia patients, regardless of the accessibility of fit donors and graft-versus-host disease. In this review, we emphasize applying CRISPR gene editing strategies for sickle cell anemia treatment, containing the genetic modification and rectification of sickle cell disease mutation in β-globin and the stimulation of fetal hemoglobin to protect cells against sickling. We summarize the importance of stem cell manipulation to cure sickle cell anemia having likely lifetime efficacy for cell and gene therapies. HIGHLIGHTS • Sickle cell disease (SCD) is a type of monogenic blood disorders. • The CRISPR/Cas9 technology can be used to treat SCD. • RBC sickling is reversed by mutation correction or fetal hemoglobin induction.

Schlagwörter

sickle cell diseaseCRISPR/Cas9 genome editingfetal hemoglobin inductionex vivo gene therapycell and gene therapysickle cell disease treatment

Zitieren

APA

Ebrahimi, V., & Hashemi, A. (2021). The Fabulous Impact of CRISPR Method in Sickle Cell Disease Treatment. Trends in Peptide and Protein Sciences. https://doi.org/10.22037/tpps.v6i.34202

Vancouver

Ebrahimi V, Hashemi A. The Fabulous Impact of CRISPR Method in Sickle Cell Disease Treatment. Trends in Peptide and Protein Sciences. 2021. doi:10.22037/tpps.v6i.34202

BibTeX
@article{Ebrahimi2021,
  author = {Ebrahimi, Vida and Hashemi, Atieh},
  title = {The Fabulous Impact of CRISPR Method in Sickle Cell Disease Treatment},
  journal = {Trends in Peptide and Protein Sciences},
  year = {2021},
  doi = {10.22037/tpps.v6i.34202}
}
Kostenlos starten →